- Home
- ATON vs NRSN Comparison
ATON vs NRSN Comparison
Compare ATON & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATON
- NRSN
- Stock Information
- Founded
- ATON 1973
- NRSN 2017
- Country
- ATON British Virgin Islands
- NRSN Israel
- Employees
- ATON N/A
- NRSN N/A
- Industry
- ATON Oil & Gas Production
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- ATON Energy
- NRSN Health Care
- Exchange
- ATON Nasdaq
- NRSN Nasdaq
- Market Cap
- ATON 37.1M
- NRSN 29.8M
- IPO Year
- ATON N/A
- NRSN 2021
- Fundamental
- Price
- ATON $2.87
- NRSN $1.24
- Analyst Decision
- ATON
- NRSN Buy
- Analyst Count
- ATON 0
- NRSN 2
- Target Price
- ATON N/A
- NRSN $14.00
- AVG Volume (30 Days)
- ATON 207.9K
- NRSN 259.3K
- Earning Date
- ATON 11-28-2025
- NRSN 12-17-2025
- Dividend Yield
- ATON N/A
- NRSN N/A
- EPS Growth
- ATON N/A
- NRSN N/A
- EPS
- ATON N/A
- NRSN N/A
- Revenue
- ATON N/A
- NRSN N/A
- Revenue This Year
- ATON N/A
- NRSN N/A
- Revenue Next Year
- ATON N/A
- NRSN N/A
- P/E Ratio
- ATON N/A
- NRSN N/A
- Revenue Growth
- ATON N/A
- NRSN N/A
- 52 Week Low
- ATON $2.82
- NRSN $0.80
- 52 Week High
- ATON $15.82
- NRSN $2.60
- Technical
- Relative Strength Index (RSI)
- ATON N/A
- NRSN 62.03
- Support Level
- ATON N/A
- NRSN $0.89
- Resistance Level
- ATON N/A
- NRSN $0.97
- Average True Range (ATR)
- ATON 0.00
- NRSN 0.08
- MACD
- ATON 0.00
- NRSN 0.02
- Stochastic Oscillator
- ATON 0.00
- NRSN 94.71
About ATON AlphaTON Capital Corp. Common Stock
AlphaTON Capital Corp is a specialized digital asset treasury company focused on building and managing a strategic reserve of TON tokens and developing the Telegram ecosystem. The company implements a comprehensive treasury strategy that combines direct token acquisition, validator operations, and strategic ecosystem investments to generate sustainable returns for shareholders. Through its operations, it provides public market investors with institutional-grade exposure to the TON ecosystem and Telegram's billion user platform.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.